Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.010
+0.120 (3.08%)
Mar 25, 2026, 4:00 PM EDT - Market closed

TriSalus Life Sciences Revenue

In the year 2025, TriSalus Life Sciences had annual revenue of $45.15M with 53.41% growth. TriSalus Life Sciences had revenue of $13.21M in the quarter ending December 31, 2025, with 59.85% growth.

Revenue (ttm)
$45.15M
Revenue Growth
+53.41%
P/S Ratio
5.44
Revenue / Employee
$442,657
Employees
102
Market Cap
245.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202545.15M15.72M53.41%
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InfuSystem Holdings143.44M
RxSight134.48M
Sight Sciences77.36M
Electromed68.86M
CVRx, Inc.56.65M
908 Devices56.20M
BrainsWay52.23M
ClearPoint Neuro36.97M
Revenue Rankings

TLSI News

More News